In today’s Pharmaceutical Executive Daily, the FDA introduces a new superiority standard for future CAR-T approvals, Relation ...

Fondazione Telethon announced that FDA has approved its Biologics License Application (BLA) for Waskyra (etuvetidigene ...

With only 11% of organizations reporting comprehensively organized and accessible data for AI applications, data readiness ...

Several high-quality systemic reviews also found that pharmacist- and nurse-led interventions—such as patient education, ...

How pharma marketers can time brand messages to prescribers when it matters most.

The collaboration agreement joins Relation’s AI-powered drug discovery platform and human data generation capabilities with ...

Pfizer announced it has entered into an exclusive global collaboration and license agreement with Chongqing Yao ...

Early real-world findings show that Carvykti, a BCMA-directed CAR T-cell therapy, is demonstrating sustained remissions in ...

Carvykti’s emerging Phase III data shows that a single early-line infusion can deliver durable, treatment-free remissions ...

Jaypirca is approved for the treatment of adults with relapsed or refractory CLL/SLL who were previously treated with a ...

In today’s Pharmaceutical Executive Daily, the FDA greenlights an expanded use of Breyanzi, Eli Lilly reports Jaypirca met ...

For Phase III trial planning, two suggestions may have merit. Include sizeable subpopulations that payers cannot easily ...